期刊文献+

金黄色葡萄球菌肠毒素A在免疫应答中的作用

The Role of Staphylococcal Enterotoxin A in the Immune Response
下载PDF
导出
摘要 目的获得重组表达、纯化金黄色葡萄球菌肠毒素A(SEA),并研究其免疫增强作用。方法利用基因工程法从金黄色葡萄球菌中克隆肠毒素A基因(sea),构建重组表达载体pET32a-sea,转化大肠杆菌(Rosetta)进行表达,并对其进行纯化;纯化后的SEA在白细胞介素2(IL-2)参与下,与半胱氨酸蛋白酶抑制剂C(CysC)进行动物免疫实验,检测其免疫增强效果。结果纯化后的SEA产量大约为40mg/L菌液,SDS-PAGE分析在27kD处有单一的目的条带;与对照组相比,SEA在IL-2的参与下与抗原共同免疫,抗体效价提高2.5倍。结论 SEA能够明显增强抗原的免疫应答效果。 Objective To recombine and purify the Staphylococcal enterotoxin A(SEA)gene and detect the immune activity of the recombinant SEA.Methods The Staphylococcal enterotoxin A(SEA)gene was cloned into the prokaryotic plasmid pET32a-sea by means of the genetic engineering method.The recombinant protein was expressed in E.coli Rosetta strains and purified by nickle affinity chromatography column.Interleukin-2(IL-2)and Cystatin C(Cys C)were used to detect the immune activity of the purified SEA.Results The SEA was expressed in E.coli Rosetta successfully and purified with a production rate of 40 mg/L.SDS-PAGE analysis showed a molecular weight of approximately 27 kDa for a subunit of the protein.The immune experiments showed that the SEA enhanced the immune activity by nearly 2.5 times.Conclusion SEA can significantly enhance the immune effect of antigen.
出处 《成都医学院学报》 CAS 2016年第5期550-552,572,共4页 Journal of Chengdu Medical College
基金 大学生创新项目(No:201513705015) 大学生创新项目(No:201513705054)
关键词 肠毒素A 基因工程 纯化 免疫应答 Staphylococcal enterotoxin A Genetic engineering Purify Immune response
  • 相关文献

参考文献3

二级参考文献40

  • 1王锦平,郭大东,吕红线.超抗原与其抗肿瘤作用研究[J].医学综述,2004,10(12):723-724. 被引量:3
  • 2White J, Herman A, Pullen AM, et al. Vβ - specific superantigen staphylococcal enterotoxin B: stimulation of mature T-cell and clonal deletion in neonatal mice. Cell, 1989, 56:27 - 35.
  • 3Fischer H, Dohisten M, Andersson U, et al. Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T-cell. J.Immunol. 1989, 144:4663-4669.
  • 4Dohlsten M, Sundstedt A, Bjorldund M, et al, Superantigen induce cytokines suppress growth of human colon-carcinoma cells, Int J Cancer 1993, 54:482-491.
  • 5Hedlund G, Dohlsten M, Petersson C, et al, Supetraantigen-based tumour therapy: in vivo activation of cytotoxin T-cell. Cancer Immunol.immunother. 1993, 36:38-42.
  • 6Hedlund G, Dohlsten M, Petersson C et al, Superantigen based tumor;In vivo activation of cytotoxic T-cell. Cance Immunother, 1993. 36:89 - 93.
  • 7Pascual V, Capra JD. B-cell superantigens[J]? Curr Biol,1991,1(5) :315 - 317.
  • 8Silverman GJ. B- cell superantigens [ J ] . Immunol Today,1997,18(8) :379 - 386.
  • 9Goodglick L, Braun J. Revenge of the microbes. Superantigensof the T and B cell lineage[J]. Am J Pathol, 1994,144(4): 623 - 636.
  • 10Huber BT. The role of superantigens in the immunobiology of retroviruses[J]. Ciba Found Symp, 1994,187:132- 140.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部